 <h1>Rivastigmine Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of rivastigmine include:</b> abdominal pain, diarrhea, dizziness, headache, nausea, vomiting, weight loss, and anorexia. <b>Other side effects include:</b> anxiety, asthenia, depression, drowsiness, dyspepsia, fatigue, tremor, diaphoresis, flatulence, and malaise.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to rivastigmine: oral capsule</i></p><p>Other dosage forms:</p><ul><li>transdermal patch extended release</li></ul><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, rivastigmine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking rivastigmine:</p><p>
<i>More common</i>
</p><ul>
<li>Diarrhea</li>
<li>indigestion</li>
<li>loss of appetite</li>
<li>loss of strength</li>
<li>nausea and vomiting</li>
<li>weight loss</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Fainting</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Aggression</li>
<li>convulsions (seizures)</li>
<li>trembling and shaking of the hands and fingers</li>
<li>trouble urinating</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Bloody or black, tarry stools</li>
<li>chest pain or discomfort</li>
<li>constipation</li>
<li>difficulty with speaking</li>
<li>drooling</li>
<li>lightheadedness, dizziness, or fainting</li>
<li>loss of balance control</li>
<li>muscle trembling, jerking, or stiffness</li>
<li>restlessness</li>
<li>severe stomach pain</li>
<li>shortness of breath</li>
<li>shuffling walk</li>
<li>slow or irregular heartbeat</li>
<li>stiffness of the limbs</li>
<li>trouble urinating</li>
<li>twisting movements of the body</li>
<li>uncontrolled movements, especially of the face, neck, and back</li>
<li>unusual tiredness</li>
<li>vomiting of blood or material that looks like coffee grounds</li>
</ul><p>
<i>Get emergency help immediately if any of the following symptoms of overdose occur while taking rivastigmine:</i>
</p><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Chest pain or discomfort</li>
<li>increased sweating</li>
<li>increased watering of the mouth</li>
<li>irregular, fast, slow, or shallow breathing</li>
<li>lightheadedness, dizziness, or fainting</li>
<li>nausea (severe)</li>
<li>pale or blue lips, fingernails, or skin</li>
<li>seizures</li>
<li>slow or irregular heartbeat</li>
<li>trouble breathing</li>
<li>unusual tiredness</li>
<li>vomiting (severe)</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of rivastigmine may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Abdominal or stomach pain or cramping</li>
<li>bloated or full feeling</li>
<li>confusion</li>
<li>dizziness</li>
<li>headache</li>
<li>mental depression</li>
<li>seeing, hearing, or feeling things that are not there</li>
<li>trouble sleeping</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>General feeling of discomfort or illness</li>
<li>runny nose</li>
</ul><p>
<div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to rivastigmine: oral capsule, oral solution, transdermal film extended release</i></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Hyperhidrosis</p>
<p><b>Rare</b> (less than 0.1%): Rash </p>
<p><b>Frequency not reported</b>: Pruritus</p>
<p><b>Postmarketing reports</b>: Stevens-Johnson syndrome disseminated allergic dermatitis<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypertension, bradycardia</p>
<p><b>Uncommon</b> (0.1% to 1%): Hypotension</p>
<p><b>Rare</b> (0.01% to 0.1%): Angina pectoris </p>
<p><b>Very rare</b> (less than 0.01%): Cardiac arrhythmia (e.g., bradycardia, atrioventricular block, atrial fibrillation, tachycardia)</p>
<p><b>Frequency not reported</b>: Sick sinus syndrome<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (47%), vomiting (31%)diarrhea (19%), abdominal pain (13%)</p>
<p><b>Common</b> (1% to 10%): Dyspepsia, salivary hypersecretion, upper abdominal pain, flatulence, eructation</p>
<p><b>Rare</b> (0.01% to 0.1%): Gastric and duodenal ulcers </p>
<p><b>Very rare</b> (less than 0.01%): GI hemorrhage, pancreatitis</p>
<p><b>Frequency not reported</b>: Some cases of severe vomiting were associated with esophageal rupture<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary incontinence</p>
<p><b>Very rare</b> (less than 0.01%): Urinary tract infection<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Elevated liver function tests, hepatitis<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Tremor (23%), dizziness (21%)</p>
<p><b>Common</b> (1% to 10%): Somnolence, bradykinesia, dyskinesia, cogwheel rigidity, hypokinesia, vertigo, psychomotor hyperactivity, gait disturbance, Parkinson gait, headache</p>
<p><b>Uncommon</b> (0.1% to 1%): Syncope, dystonia</p>
<p><b>Rare</b> (0.01% to 0.1%): Seizures<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia, confusion, depression, anxiety, hallucination, agitation, restlessness, nightmares<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Application site erythema, application site irritation (e.g., pruritus, rash)</p>
<p><b>Postmarketing reports</b>: Application site hypersensitivity, urticaria, blister, allergic dermatitis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Anorexia (17%)</p>
<p><b>Common</b> (1% to 10%): Decreased appetite</p>
<p><b>Frequency not reported</b>: Dehydration<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Asthenia, weight loss, fatigue, malaise, fall<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Rhinitis<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Monastero R,  Lopez G,  Mannino M,  Camarda R "Erythematous maculopapular eruption due to rivastigmine therapy." Am J Med 111 (2001): 583-4</p><p id="ref_3">3. Kayrak M,  Yazici M,  Ayhan SS,  Koc F,  Ulgen MS "Complete atrioventricular block associated with rivastigmine therapy." Am J Health Syst Pharm 65 (2008): 1051-3</p><p id="ref_4">4. "Product Information. Exelon (rivastigmine)" Novartis Pharmaceuticals, East Hanover, NJ. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about rivastigmine</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>29 Reviews</li>
<li>Drug class: cholinesterase inhibitors</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Rivastigmine transdermal</li>
<li>Rivastigmine &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Rivastigmine Transdermal &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Exelon</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +3 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Lewy Body Dementia</li>
<li>Alzheimer's Disease</li>
<li>Parkinson's Disease</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to rivastigmine: oral capsule, oral solution, transdermal film extended release</i></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Hyperhidrosis</p><p><b>Rare</b> (less than 0.1%): Rash </p><p><b>Frequency not reported</b>: Pruritus</p><p><b>Postmarketing reports</b>: Stevens-Johnson syndrome disseminated allergic dermatitis<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypertension, bradycardia</p><p><b>Uncommon</b> (0.1% to 1%): Hypotension</p><p><b>Rare</b> (0.01% to 0.1%): Angina pectoris </p><p><b>Very rare</b> (less than 0.01%): Cardiac arrhythmia (e.g., bradycardia, atrioventricular block, atrial fibrillation, tachycardia)</p><p><b>Frequency not reported</b>: Sick sinus syndrome<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (47%), vomiting (31%)diarrhea (19%), abdominal pain (13%)</p><p><b>Common</b> (1% to 10%): Dyspepsia, salivary hypersecretion, upper abdominal pain, flatulence, eructation</p><p><b>Rare</b> (0.01% to 0.1%): Gastric and duodenal ulcers </p><p><b>Very rare</b> (less than 0.01%): GI hemorrhage, pancreatitis</p><p><b>Frequency not reported</b>: Some cases of severe vomiting were associated with esophageal rupture<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary incontinence</p><p><b>Very rare</b> (less than 0.01%): Urinary tract infection<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Elevated liver function tests, hepatitis<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Tremor (23%), dizziness (21%)</p><p><b>Common</b> (1% to 10%): Somnolence, bradykinesia, dyskinesia, cogwheel rigidity, hypokinesia, vertigo, psychomotor hyperactivity, gait disturbance, Parkinson gait, headache</p><p><b>Uncommon</b> (0.1% to 1%): Syncope, dystonia</p><p><b>Rare</b> (0.01% to 0.1%): Seizures<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia, confusion, depression, anxiety, hallucination, agitation, restlessness, nightmares<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Application site erythema, application site irritation (e.g., pruritus, rash)</p><p><b>Postmarketing reports</b>: Application site hypersensitivity, urticaria, blister, allergic dermatitis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Anorexia (17%)</p><p><b>Common</b> (1% to 10%): Decreased appetite</p><p><b>Frequency not reported</b>: Dehydration<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Asthenia, weight loss, fatigue, malaise, fall<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Rhinitis<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Monastero R,  Lopez G,  Mannino M,  Camarda R "Erythematous maculopapular eruption due to rivastigmine therapy." Am J Med 111 (2001): 583-4</p><p id="ref_3">3. Kayrak M,  Yazici M,  Ayhan SS,  Koc F,  Ulgen MS "Complete atrioventricular block associated with rivastigmine therapy." Am J Health Syst Pharm 65 (2008): 1051-3</p><p id="ref_4">4. "Product Information. Exelon (rivastigmine)" Novartis Pharmaceuticals, East Hanover, NJ. </p><h2>More about rivastigmine</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>29 Reviews</li>
<li>Drug class: cholinesterase inhibitors</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Rivastigmine transdermal</li>
<li>Rivastigmine &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Rivastigmine Transdermal &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +3 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Lewy Body Dementia</li>
<li>Alzheimer's Disease</li>
<li>Parkinson's Disease</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>